Literature DB >> 9082980

The receptor for the cytotoxic ligand TRAIL.

G Pan1, K O'Rourke, A M Chinnaiyan, R Gentz, R Ebner, J Ni, V M Dixit.   

Abstract

TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor (TNF) ligand family that rapidly induces apoptosis in a variety of transformed cell lines. The human receptor for TRAIL was found to be an undescribed member of the TNF-receptor family (designated death receptor-4, DR4) that contains a cytoplasmic "death domain" capable of engaging the cell suicide apparatus but not the nuclear factor kappa B pathway in the system studied. Unlike Fas, TNFR-1, and DR3, DR4 could not use FADD to transmit the death signal, suggesting the use of distinct proximal signaling machinery. Thus, the DR4-TRAIL axis defines another receptor-ligand pair involved in regulating cell suicide and tissue homeostasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9082980     DOI: 10.1126/science.276.5309.111

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  429 in total

Review 1.  Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.

Authors:  B G Darnay; B B Aggarwal
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  TVB receptors for cytopathic and noncytopathic subgroups of avian leukosis viruses are functional death receptors.

Authors:  J Brojatsch; J Naughton; H B Adkins; J A Young
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses.

Authors:  Daniel J Knauss; John A T Young
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  B lymphocytes are resistant to death receptor 5-induced apoptosis.

Authors:  Roslyn N Crowder; Hong Zhao; W Winn Chatham; Tong Zhou; Robert H Carter
Journal:  Clin Immunol       Date:  2011-01-28       Impact factor: 3.969

5.  Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Sophia Tseleni-Balafouta; Avi Ashkenazi; Demetrios A Koutras; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Results on efficacy and safety of cancer treatment with or without tumor necrosis factor-related apoptosis-inducing ligand-related agents: A meta-analysis.

Authors:  Shaoxing Sun; Zonghuan Li; Li Sun; Chunxu Yang; Zijie Mei; Wen Ouyang; Bo Yang; Conghua Xie
Journal:  Mol Clin Oncol       Date:  2014-02-18

7.  Synergistic induction of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying TRAIL.

Authors:  Qiuwei Pan; Bisheng Liu; Jin Liu; Rong Cai; Yigang Wang; Cheng Qian
Journal:  Mol Cell Biochem       Date:  2007-06-19       Impact factor: 3.396

8.  Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.

Authors:  Tai-Guang Jin; Alexei Kurakin; Nordine Benhaga; Karon Abe; Mehrdad Mohseni; Ferry Sandra; Keli Song; Brian K Kay; Roya Khosravi-Far
Journal:  J Biol Chem       Date:  2004-10-14       Impact factor: 5.157

Review 9.  Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand.

Authors:  Nor Saadah M Azahri; Mary M Kavurma
Journal:  Cell Mol Life Sci       Date:  2013-01-18       Impact factor: 9.261

10.  Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

Authors:  Teresa Troiani; Erika Martinelli; Floriana Morgillo; Anna Capasso; Anna Nappi; Vincenzo Sforza; Fortunato Ciardiello
Journal:  Ther Adv Med Oncol       Date:  2013-01       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.